#Coronavirus Disease Research #References (AMEDEO, May 23 '26)

 

Am J Respir Crit Care Med

1. KRAMER L, Calfee CS, Mcauley DF, O'Kane C, et al
   Interleukin-6 is a mediator of therapeutic efficacy in acute lung injury.
   Am J Respir Crit Care Med. 2026 Apr 28:aamag213. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. MILLER M, Fischer S, Azrael D
   Firearm Acquisition and New Exposure to Household Firearms After the Initial Pandemic Purchasing Surge: Results From the 2024 National Firearms Survey.
   Ann Intern Med. 2026;179:637-644.
   PubMed         Abstract available
   
   

   
   Antiviral Res

3. LOISON S, Chabert M, Gensous C, Constant S, et al
   Cell-Type Specific Effects of SARS-CoV-2 P252L Mutation on Nirmatrelvir Sensitivity.
   Antiviral Res. 2026 May 19:106445. doi: 10.1016/j.antiviral.2026.106445.
   PubMed         Abstract available
   
   
4. PAGLIARI M, Lutken C, Vianello L, Mazzacan E, et al
   LTX-109 as a broad-spectrum antiviral: in vitro and in vivo efficacy against SARS-CoV-2 and Influenza Viruses.
   Antiviral Res. 2026 May 19:106444. doi: 10.1016/j.antiviral.2026.106444.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

5. ERIGUCHI Y, Shimono N
   Declining antibiotic consumption and changing sexually transmitted infection dynamics in Japan: a national ecological time-series analysis, 2013-2024.
   Int J Infect Dis. 2026 May 16:108804. doi: 10.1016/j.ijid.2026.108804.
   PubMed         Abstract available
   
   
6. MA Q, Yao L, Shang H, Han X, et al
   Reply to comment on SARS-CoV-2 variant-specific humoral immunity and long-term immune recovery in people living with HIV in the ancestral vaccine era.
   Int J Infect Dis. 2026 May 17:108812. doi: 10.1016/j.ijid.2026.108812.
   PubMed        
   
   
7. ABERA EG, Kisch R, Ali S, Tsegaye W, et al
   Dynamics and variant-specific patterns of SARS-CoV-2 reinfection in Ethiopia: a prospective longitudinal cohort study.
   Int J Infect Dis. 2026 May 18:108814. doi: 10.1016/j.ijid.2026.108814.
   PubMed         Abstract available
   
   

   
   J Infect

8. MUNRO AP, Ferrari M, Kinsley R, Egan D, et al
   A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus Vaccine.
   J Infect. 2026 May 18:106759. doi: 10.1016/j.jinf.2026.106759.
   PubMed         Abstract available
   
   
9. GUINOVART LJ, Westrhenen SEMH, Schuurman R, Bruijning-Verhagen PCJL, et al
   Symptomatology of SARS-CoV-2 versus seasonal coronavirus infection in healthy young children.
   J Infect. 2026 May 20:106762. doi: 10.1016/j.jinf.2026.106762.
   PubMed         Abstract available
   
   

   
   J Med Virol

10. BU GL, Chen LN, Wu PH, Zeng MS, et al
    Preventing Both EBV Infection and EBV-Associated Diseases: Advances in Vaccine Research.
    J Med Virol. 2026;98:e70961.
    PubMed         Abstract available
    
    
11. FUKUDA Y, Fujii Y, Togashi A, Nawa T, et al
    Recent Increase in Rotavirus Gastroenteritis After Five Years of Low Activity in Hokkaido Prefecture, Japan, Associated With Equine-Like G3P[8] and G8P[8] Strains, 2025.
    J Med Virol. 2026;98:e70967.
    PubMed         Abstract available
    
    
12. SANSONE NMS, Costa PT, Mello LS, Marques LFA, et al
    Vaccination Coverage Against Coronavirus Disease 2019 (COVID-19) in Brazil's Indigenous Population.
    J Med Virol. 2026;98:e70965.
    PubMed         Abstract available
    
    
13. HORI M, Hayama-Terada M, Kitamura A, Hosozawa M, et al
    Prevalence and Risk Factors for Persistent Post-COVID-19 Condition at 3, 6, 12, and 18 Months After Initial Infection Among Adults Living in a Community of Japan: Yao COVID-19 Study.
    J Med Virol. 2026;98:e70973.
    PubMed         Abstract available
    
    
14. YENOKYAN K, Wentz E, Ni Z, Kammerling T, et al
    Association of Comorbid and Incident Depression and Other Mental Health Conditions With Long-COVID: Results From the Johns Hopkins COVID Long Study.
    J Med Virol. 2026;98:e70970.
    PubMed         Abstract available
    
    

    
    J Virol

15. YAN P, Kyaw ZO, Wang X, Li N, et al
    Febrifugine dihydrochloride restricts porcine epidemic diarrhea virus replication by modulating the IGF1R-driven PI3K/AKT-apoptosis axis.
    J Virol. 2026;100:e0011726.
    PubMed         Abstract available
    
    
16. HUANG M, Liukang C, Yang H, Sun L, et al
    Infectious bronchitis virus accessory protein 3a induces renal inflammatory injury by activating the NLRP3 inflammasome via ER calcium mobilization and mitochondrial ROS production.
    J Virol. 2026;100:e0212525.
    PubMed         Abstract available
    
    
17. SCHIFFER JT, Reeves DB, Mayer B, Rodriguez LR, et al
    Clinical trial simulation of antiviral drugs.
    J Virol. 2026;100:e0181424.
    PubMed         Abstract available
    
    
18. SIVARAJAN R, Kirchgatterer PC, Lawrenz J, Tanner-Matiz E, et al
    Tonic and early interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures.
    J Virol. 2026 May 20:e0210425. doi: 10.1128/jvi.02104.
    PubMed         Abstract available
    
    

    
    Lancet

19. ISLAM MS, Chughtai AA, Wood JG, Sawleshwarkar S, et al
    Hantavirus outbreak on a cruise ship in the South Atlantic.
    Lancet. 2026 May 15:S0140-6736(26)00934-7. doi: 10.1016/S0140-6736(26)00934.
    PubMed        
    
    

    
    Nature

20. AYGUN E, Belyaeva A, Comanici G, Coram M, et al
    An AI system to help scientists write expert-level empirical software.
    Nature. 2026 May 19. doi: 10.1038/s41586-026-10658.
    PubMed         Abstract available
    
    
21. KOZLOV M
    Exclusive: NIH ousts infectious-disease leaders as COVID scientists face US charges.
    Nature. 2026 May 15. doi: 10.1038/d41586-026-01558.
    PubMed        
    
    

    
    Science

22. COHEN J
    Virologist accused of starting COVID-19 fights funding ban.
    Science. 2026;392:795-796.
    PubMed         Abstract available
    
    

    
    Travel Med Infect Dis

23. LI D, Tian F, Niu Y, Li H, et al
    Surveillance of Airborne Microorganisms and Associated Influencing Factors at an International Airport in China, 2019-2020.
    Travel Med Infect Dis. 2026 May 19:102992. doi: 10.1016/j.tmaid.2026.102992.
    PubMed         Abstract available
    
    
24. POLONI A, Rizzo A, Giacomelli A, Colaneri M, et al
    D-dimer as a marker of severe disease in imported malaria: a retrospective observational study.
    Travel Med Infect Dis. 2026;72:102994.
    PubMed         Abstract available